Johnson & Johnson’s COVID-19 Vaccine Approved by FDA

119
"201214-D-BN624-0328" (CC BY 2.0) by U.S. Secretary of Defense

Vaccines against coronavirus are being distributed and administered across the United States. Just last week, Joe Biden, Kamala Harris, and White House doctors celebrated the delivery of 50 million vaccinations against COVID-19.

“Maryland National Guard” (CC BY 2.0) by The National Guard

The COVID-19 vaccine continues to face mixed reactions, despite the political and healthcare communities’ insistence of this injection’s safety. Several reports exist of adverse reactions to the coronavirus vaccine. Many healthcare workers have also refused the vaccine, as have others in frontline and essential occupations.


According to Townhall, the Food and Drug Administration (FDA) on Saturday approved a third COVID-19 vaccination.

The Johnson & Johnson Coronavirus Vaccine

On Saturday, Johnson & Johnson’s COVID-19 vaccine received the mandatory stamp of approval from the FDA. Unlike the Moderna and Pfizer vaccines, Johnson & Johnson’s coronavirus shot only requires one dose.

According to data, the Johnson & Johnson coronavirus vaccine is 85% effective against the most egregious infections, yet only 66% effective against mild to serious coronavirus diagnoses. Furthermore, a clinical study involving 44K individuals indicates that the Johnson & Johnson vaccine has a 100% rate of preventing the need for coronavirus hospitalizations.

The necessary storage for the Johnson & Johnson COVID-19 vaccine furthermore varies from that of the Pfizer and Moderna brands. Johnson & Johnson’s vaccine can last for months at room temperature storage.

This week is set to mark the start of Johnson & Johnson’s coronavirus vaccine shipments. Roughly three to four million doses will be sent out. Moreover, Johnson & Johnson seeks to have 20 million doses exported by April 2021 and 100 million doses towards the end of June 2021.

Administering the Johnson & Johnson Coronavirus Vaccine

At state and federal levels, vaccination sites and facilities are being set up. The Biden administration has already vowed to engage in efforts to get the COVID-19 vaccine to underserved communities.

With the rollout of the Johnson & Johnson vaccine, Americans can expect more promotion of the coronavirus vaccine from the White House. In Texas, last week, Biden urged the American public to receive a coronavirus vaccine when they can and also proceed with social distancing and mask-wearing.

The FDA’s approval of the Johnson & Johnson coronavirus vaccine has still not erased many of the concerns that Americans have regarding this injection. Many proponents of the coronavirus vaccine have also failed to directly address the apprehensions held by many Americans.

What do you make of the FDA’s approval of the Johnson & Johnson coronavirus vaccine? Let us know down below in the comments section.